ISDR yields 20.73% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 9
Combined, ISDR + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ISDR + ABBV for your $10,000?
Issuer Direct Corporation provides shareholder communications and compliance platforms, technologies, and services in the United States and internationally. The company provides Platform id., a platform that manages the events of customers to distribute their messages to constituents, investors, markets, and regulatory systems; whistleblower hotline, which delivers secure notifications and basic incident workflow management processes that align with a company's corporate governance whistleblower policy; proxy module, a real-time voting platform for customers and their shareholders of record; and stock transfer module, a cloud-based platform, which provides access to real-time information about their shareholders, stock ledgers, and reports, as well as issues new shares. It also offers ACCESSWIRE, a news dissemination and media outreach service; and VisualWebcaster Platform, a cloud-based webcast, webinar, and virtual meeting platform that delivers live and on-demand streaming of events to audiences of various sizes, as well as allows customers to create, produce, and deliver events. In addition, the company provides investor relations content network, a series of data feeds, which include news feeds, stock feeds, fundamentals, regulatory filings, corporate governance, and other components; and professional conference and events software, a mobile app that offers organizers, issuers, and investors to register, request, and approve one-on-one meetings, as well as manage schedules, perform event promotion and sponsorship, print attendee badges, and manage lodging. It serves individuals, corporate issuers, public and private companies, law firms, brokerage firms, investment banks, and mutual funds; and professional firms, such as investor relations and public relations firms, as well as the accounting and legal communities. Issuer Direct Corporation was incorporated in 1988 and is headquartered in Raleigh, North Carolina.
Full ISDR Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.